Iman Schultz

Iman Schultz

PhD – Director R&D

  • Master’s degree in Medical Molecular Biology, University of Groningen, The Netherlands (1999)
  • PhD in Translational Oncology, Radboud University Nijmegen, The Netherlands (2001-2006)
  • Postdoctoral studies at the Brigham & Women’s Hospital/Harvard Medical School, Boston, US (2007-2010)
  • Oncology Drug Development at InteRNA Technologies BV, Utrecht, The Netherlands (2010-2018):
    • Research Scientist (2 years): Drug screening, Lead identification
    • Senior Scientist (2 years): Lead Optimization, Drug Pharmacology, PK/PD
    • Project Manager R&D (3 years): Managing the R&D department, supporting GLP Data Documentation for IMPD/IND filing of lead candidate
  • Consultant at FFUND BV, Abcoude, The Netherlands (2018/2019):
    •  IP Management support for clients
    • Securing Financial support for clients
  • Joined Pantarhei as of January 1, 2020, as Director R&D
  • Joined Pandora Endocrine Innovation as of January 1, 2020, as Director R&D